Repositorio Dspace

Listar02. Servicio Murciano de Salud (SMS) por tema "Stroke Volume"

Listar02. Servicio Murciano de Salud (SMS) por tema "Stroke Volume"

Ordenar por:Orden:Resultados:

  • Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction 
    Amiguet, Martina; Palau, Patricia; Domínguez, Eloy; Seller, Julia; Pinilla, Jose-Manuel-Garcia; de-la-Espriella, Rafael; Miñana, Gema; Valle, Alfonso; Sanchis, Juan; Górriz, Jose-Luis; Bayés-Genís, Antoni; Domíngueza, Eloy; Sastre, Clara; Santas, Enrique; Mollar, Anna; Civera, Jose; Conesa, Adriana; Zakarne, Rim; Larumbe, Ainoha; Doblas, Juan-Jose-Gómez; Mezcua, Ainhoa-Robles; Bodí, Vicent; Pascual-Figal, Domingo; Rubio, Clara-Jiménez; Cabeza, Alejandro-I-Pérez; Expósito, Arancha-Díaz; Carmona, José-David-Martínez; Morales, Manuel-Luna; Sánchez, Francisco-J-Zafra; Trujillo, Ángel-Montiel; Climent, Herminio-Morillas; Núñez, Julio (Nature Research, 2023)
    Circulating antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload in heart failure. This study aimed to evaluate the effect of dapagliflozin on short-term CA125 levels in patients with stable heart ...
  • Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study 
    Pascual-Figal, Domingo-A; Zamorano, J-Luis; Domingo, Mar; Morillas, Herminio; Nuñez, Julio; Cobo-Marcos, Marta; Riquelme-Pérez, Alejandro; Teis, Albert; Santas, Enrique; Caro-Martinez, Cesar; Pinilla, Jose-Manuel; Rodriguez-Palomares, Jose-F; Dobarro, David; Restrepo-Córdoba, M-Alejandra; González-Juanatey, J-Ramón; Bayés-Genís, Antoni (John Wiley and Sons Ltd, 2023)
    AIMS: Dapagliflozin improves the prognosis of patients with heart failure (HF), regardless of left ventricular ejection fraction (LVEF). However, its effect on cardiac remodelling parameters, specifically left atrial (LA) ...
  • Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study 
    Revuelta-López, Elena; Nunez, Julio; Gastelurrutia, Paloma; Cediel, German; Januzzi, James-L; Ibrahim, Nasrien-E; Emdin, Michele; VanKimmenade, Roland; Pascual-Figal, Domingo-Andrés; Nunez, Eduardo; Gommans, Frank; Lupon, Josép; Bayes-Genis, Antoni (WILEY PERIODICALS, INC, 2020-04)
    AIM: Sacubitril/valsartan is a first-in-class angiotensin receptor-neprilysin inhibitor developed for the treatment of heart failure with reduced ejection fraction. Its benefits are achieved through the inhibition of ...
  • Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction 
    Verstraelen, Tom-E; Van-Lint, Freyja-H-M; Bosman, Laurens-P; De-Brouwer, Remco; Proost, Virginnio-M; Abeln, Bob-G-S; Taha, Karim; Zwinderman, Aeilko-H; Dickhoff, Cathelijne; Oomen, Toon; Schoonderwoerd, Bas-A; Kimman, Gerardus-P; Houweling, Arjan-C; Gimeno-Blanes, Juan-R; Asselbergs, Folkert-W; Van-Der-Zwaag, Paul-A; De-Boer, Rudolf-A; Van-Den-Berg, Maarten-P; Van-Tintelen, J-Peter; Wilde, Arthur-A-M (Oxford University Press, 2021)
    AIMS: This study aims to improve risk stratification for primary prevention implantable cardioverter defibrillator (ICD) implantation by developing a new mutation-specific prediction model for malignant ventricular arrhythmia ...

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta